
Molly Franke
@mollyfranke1
assoc prof @harvardmed, epidemiologist, TB, adolescent health, epi methods
ID: 805642166907367424
05-12-2016 05:17:15
314 Tweet
478 Takipçi
422 Takip Edilen




Join us tomorrow morning for a great symposium at the #UnionConf2023 (SP24) on new methods to analyze observational MDR/RR-TB treatment cohorts Molly Franke



What a moment! THREE shortened regimens noninferior to the longer standard of care. Hats off to endTB Partners In Health MSF International and IRD Global for this groundbreaking work!


Dr. Girum B. Tefera has treated patients with MDR-TB for many years—from his home country of Ethiopia to now Sierra Leone 🫁🩺 Currently, he leads the MDR-TB care at PIH Sierra Leone-supported Lakka Government Hospital. Watch the video to learn more: bit.ly/3HjKY3k

Sign up by Feb 7 to receive feedback on your HIV-related K Application! Free/open to all Harvard-affiliated investigators Harvard Medical School Ragon Institute Mass General Brigham MGH Division of Infectious Diseases Harvard T.H. Chan School of Public Health Fenway Health BIDMC @MGH_RI Dana-Farber Molly Franke Info conta.cc/3Hs5EpU




Especially if it comes from this aligned coffee shop, a neighbor to Danaher Corporation!



Cost for each cartridge was estimated to be $3-4 when sales volumes were a small fraction of what they r today. So, cost is even lower today. Selling for $5 would generate huge profits. Danaher Corporation still price-gouges while celebrating the growing market share. #Shame

The TARGET Reporting Guideline team needs your help. If you work on #causalinference from observational data, please get involved in piloting the reporting guidelines for #TargetTrial emulation. Diverse viewpoints will make the guidelines more useful for everyone in #RWE. More info👇


